Table 4.
Fctors | P-values | ||
---|---|---|---|
Age at diagnosis (>16yrs) | 0.6809 | ||
Gender | 0.3071 | ||
NOD2 risk allele carriage | 0.1408 | ||
Cohort | 0.2269 | ||
Smoking | 0.0044 | ||
Elevated GM-CSF Ab | 0.0108 | ||
Perianal location | 0.0029 | ||
Smoking* Elevated GM-CSF Ab | 0.0023 | ||
Cohort*Smoking | 0.0010 | ||
Cohort*Smoking* Elevated GM-CSF Ab | 0.0048 | ||
Factors | By Smoking | By Cohort | OR (95%CI) |
GM-CSF Ab
Elevation Yes vs. No |
Yes | Brisbane | 0.19 (0.04–0.81) |
NIDDK | 2.67 (0.88–8.06) | ||
No | Brisbane | 2.27 (1.21–4.26) | |
NIDDK | 2.25 (1.21–4.25) |
A multiple logistic regression model was fitted with Ileal CD location as the response variable. Main effects for the variables age at diagnosis, gender, NOD2 allele, Cohort, Smoking, elevated GM-CSF Ab (≥ 5mcg/mL), and Perianal location were included in the model automatically, while interaction terms between these main effects were included only if significant after backward elimination. Table 4 displays the p-values for all fitted terms in the final model, as well as the estimated odds ratios for association of Ileal CD location with Elevated GM-CSF-Ab. The odds ratio estimates were broken down by smoking and cohort as the significant association was defined by interactions of elevated GM-CSF-Ab with smoking and cohort.